Shima, Israel

Sergey Kirilov


Average Co-Inventor Count = 5.0

ph-index = 1


Location History:

  • Shima, IL (2022)
  • Haifa, IL (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Sergey Kirilov in Tumor Treatment Technology.

Introduction

Sergey Kirilov is a notable inventor based in Shima, Illinois, recognized for his contributions to medical technology, particularly in the field of tumor treatment. With a total of 2 patents, Kirilov has made significant strides in enhancing the effectiveness of tumor treating fields (TTFields).

Latest Patents

Kirilov's latest patents focus on the delivery of tumor treating fields (TTFields) using arrays with selectively addressable sub-elements. This innovative approach allows for the delivery of TTFields at higher field strengths by selectively switching off overheating electrode elements while maintaining the functionality of those that are not overheating. The system employs multiple temperature sensors positioned at each electrode element to monitor temperature, along with electrically controlled switches that manage the current flow to individual electrodes. A controller processes input from the temperature sensors to ensure optimal performance and safety during treatment.

Career Highlights

Sergey Kirilov is currently associated with Novocure GmbH, a company dedicated to advancing cancer treatment technologies. His work has been pivotal in developing methods that improve patient outcomes through innovative medical devices.

Collaborations

Kirilov collaborates with esteemed colleagues such as Yoram Wasserman and Michael Krinitsky, contributing to a team that is at the forefront of cancer treatment innovation.

Conclusion

Sergey Kirilov's work exemplifies the intersection of technology and medicine, showcasing how innovative inventions can lead to improved treatment options for patients battling cancer. His contributions continue to influence the field of tumor treatment significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…